accountThe prices of multiple sclerosis medicines have risen as much as 39 percent since last year, even as competition intensified with the introduction of the first pill to treat the disease. Teva Pharmaceutical Industries...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to New Novartis MS Drug Spurs U.S. Price Rise
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account